Aston PA., September 16, 2022 – DRW Medical LLC announced today that the U.S. Food and Drug Administration has cleared the Exsalta device for use on patients as indicated. Exsalta is the first peristaltic suction device for clearing endotracheal tube secretions for patients on ventilators. Its exceptional low flow technology, available at any suction setting, reduces risk of negative pressures in […]

Exsalta is the first peristaltic suction device for clearing endotracheal tube secretions for patients on ventilators. Its exceptional low flow technology, available at any suction setting, reduces risk of negative pressures in the lungs to help prevent alveolar collapse and hypoxia. Exsalta is a smart secretion clearance solution for patients in whom the standard wall […]